FDA warns that buprenorphine causes dental problems
The use of transmucosal buprenorphine, a drug prescribed to treat opioid use disorder and pain, may cause dental problems, according to a warning issued January 12 from the U.S. Food and Drug Administration (FDA). Reports of dental problems include oral infections, as well as tooth decay and loss, even in patients with no history of oral health issues. The reports have triggered the FDA to require that a new warning

